The question people always ask is, “Where did they get the money to grow to 500 trucks?” It’s all in the model, and it’s ...

The Company also confirms that in connection with the appointment of Krysta Davies Foss to the board of directors, XORTX has ...

A wide of array of advanced controllers arrived in 2025, marked by high integration and enhanced intelligence in solutions ...

Researchers at Children's Hospital of Philadelphia (CHOP) pioneered a standardized approach for heart recovery in children using ventricular assist devices (VAD), as reported in the Journal of the ...

Re:Public reports that America's trails are vanishing due to climate change, underfunding, and poor maintenance, risking ...

The 74 reports on the school-to-asylum pipeline ending due to a landmark lawsuit, reshaping educational rights for disabled ...

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused ...

Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to 2029—click here to read now.

Scientists have discovered key genetic factors that determine whether a T cell acts as a powerful disease fighter or enters ...

Equity Insider News Commentary ? Defense is no longer about physical walls; it is about the digital shield that protects them ...

Cory Doctorow and Tim Wu explain why the internet failed to live up to its early promise.

The trick, I’m told, with GLP-1 receptor agonist drugs like Ozempic, is to not just take the dose and let the drugs work on ...